Upinder Singh MD
Professor and Division Chief, Infectious Diseases, Stanford University Medical Center
Join to View Full Profile
200 Hawkins DrIowa City, IA 52242
Phone+1 319-356-4379
Fax+1 319-356-4379
Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Virginia Medical CenterFellowship, Infectious Disease, 1995 - 1998- University of Virginia Medical CenterResidency, Internal Medicine, 1992 - 1995
Ohio State University College of MedicineClass of 1992
Certifications & Licensure
IA State Medical License 2025 - 2027
CA State Medical License 2002 - 2025
VA State Medical License 1995 - 2002
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Clinical Trials
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol Start of enrollment: 2021 Apr 23
Publications & Presentations
PubMed
- 1 citationsEfficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study.Onyema Ogbuagu, Jason D Goldman, Robert L Gottlieb, Upinder Singh, Masaharu Shinkai
The Lancet. Infectious Diseases. 2025-12-01 - Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort.Tanayott Thaweethai, Sarah E Donohue, Jeffrey N Martin, Mady Hornig, Jarrod M Mosier
Nature Communications. 2025-11-17 - Longitudinal Patient-Reported Outcome Trajectories in Long COVID: Findings From the STOP-PASC Clinical Trial.Prasanna Jagannathan, Haley Hedlin, Jane W Liang, Blake Shaw, Evan Maestri
Open Forum Infectious Diseases. 2025-10-01
Journal Articles
- Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist WorkforceWendy Armstrong, Ebbing Lautenbach, Kyle J Popovich, C Buddy Creech, Roger Bedimo, Upinder Singh, Jatin M Vyas, The Journal of Infectious Diseases
Press Mentions
Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers ReportJanuary 6th, 2025- Nirmatrelvir-Ritonavir and Symptoms in Adults with Postacute Sequelae of SARS-CoV-2 InfectionJune 7th, 2024
- Long Covid Patients Abandon Stanford Medicine Study on Infection After Staff Stop Wearing MasksMay 8th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
